CRISPR Therapeutics (CRSP) Jumps 9.6% on Biotech Rally

CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the 10 Stocks Going Wild.

Crispr Therapeutics rallied for a second day on Wednesday, adding 9.6 percent to close at $60.08 apiece, tracking the rally in the biotechnology sector and the broader market.

During the session, the biotechnology industry rose by 3.58 percent amid a flurry of developments in the sector. Meanwhile, Wall Street’s main indices all finished in the green territory.

Additionally, investors may have begun repositioning portfolios ahead of the release of second-quarter earnings results. Based on its historical reporting dates, CRISPR Therapeutics AG (NASDAQ:CRSP) will announce its financial and operating results in the first week of August.

CRISPR Therapeutics (CRSP) Jumps 9.6% on Biotech Rally

A laboratory cultivating cells for the development of gene and cell therapies.

In the first quarter of the year, CRISPR Therapeutics AG (NASDAQ:CRSP) widened its net loss by 17 percent to $136 million from $116 million previously.

Revenues, however, jumped by 71.6 percent to $865 million from $504 million year-on-year.

While we acknowledge the risk and potential of CRSP as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than CRSP and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.